Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Exelixis Inc
(NQ:
EXEL
)
26.42
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Exelixis Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
Analyst Expectations for Exelixis's Future
August 02, 2023
Via
Benzinga
Exelixis (EXEL) Q2 2023 Earnings Call Transcript
August 02, 2023
EXEL earnings call for the period ending June 30, 2023.
Via
The Motley Fool
Biotech Battlefields: 3 Stocks to Watch Amid Wall Street Turmoil
July 29, 2023
There is opportunity in a crisis. Key biotech stocks amid turmoil could be the greatest deals on the market today.
Via
InvestorPlace
2 Biotech Growth Stocks I'd Buy Right Now
July 27, 2023
Both drugmakers seem to have a bright future ahead.
Via
The Motley Fool
The 3 Most Undervalued Biotech Stocks to Buy Now: July 2023
July 20, 2023
These are the three bargain biotech stocks showcasing massive upside potential for investors looking to find a position in the sector.
Via
InvestorPlace
3 No-Brainer Stocks to Buy With $200 Right Now
June 21, 2023
A modest amount of money can go a long way when it's invested in game-changing businesses.
Via
The Motley Fool
8 Analysts Have This to Say About Exelixis
May 10, 2023
Via
Benzinga
Exelixis (EXEL) Q1 2023 Earnings Call Transcript
May 10, 2023
EXEL earnings call for the period ending March 31, 2023.
Via
The Motley Fool
Exelixis: Q1 Earnings Insights
May 09, 2023
Via
Benzinga
What 9 Analyst Ratings Have To Say About Exelixis
April 12, 2023
Via
Benzinga
The Smartest Stocks to Buy With $20 Right Now and Hold Forever
May 29, 2023
These companies can take investors on a lucrative ride, and all for the price of a few lattes.
Via
The Motley Fool
2 Under-the-Radar Biotech Stocks to Buy in 2023
May 24, 2023
Companies that don't make a lot of noise can still make you a lot of money.
Via
The Motley Fool
2 Unstoppable Growth Stocks to Buy in 2023 and Beyond
May 20, 2023
Both Axsome Therapeutics and Exelixis have potentially game-changing products in their pipelines.
Via
The Motley Fool
Nasdaq Bear Market: 5 Exceptional Growth Stocks You'll Regret Not Buying on the Dip
May 13, 2023
A sizable dip in the innovation-driven Nasdaq Composite is the perfect excuse for investors to pounce on some phenomenal deals.
Via
The Motley Fool
Amid Proxy Challenge From Farallon, Exelixis' Board Member Resigns
May 08, 2023
Exelixis Inc's (NASDAQ: EXEL) board member Lance Willsey announced his resignation from the Board,
Via
Benzinga
The Smartest Stocks to Buy With $20 Right Now and Hold Forever
April 22, 2023
These cheap stocks have the potential to skyrocket over the long haul.
Via
The Motley Fool
Why Exelixis Stock Leaped More Than 4% Higher Today
March 20, 2023
Oh, how some investors love stock buyback programs.
Via
The Motley Fool
Analyst Ratings for Exelixis
March 20, 2023
Via
Benzinga
2 Stocks to Buy With Less Than $20
March 10, 2023
Some relatively low-priced shares can be good buys, too.
Via
The Motley Fool
Nasdaq Bear Market: 5 Sensational Growth Stocks You'll Regret Not Buying on the Dip
April 22, 2023
Opportunistic investors would be wise to pounce on innovative growth stocks following a 33% decline in the Nasdaq Composite.
Via
The Motley Fool
2 Under-the-Radar Biotech Stocks to Buy in 2023
April 05, 2023
Both companies have game-changing product portfolios that should result in stock price growth.
Via
The Motley Fool
Facebook Turns To Generative AI For Help, FedEx Consolidates, UBS Executives Say Surprise Credit Suisse Deal 'Major Challenge:' Today's Top Stories
April 05, 2023
Benzinga
Via
Benzinga
Farallon Capital Might Undertake Proxy Fight Against Exelixis, Nominates Three Directors
April 05, 2023
Via
Benzinga
2 Incredible Stocks to Buy With Less Than $25
April 04, 2023
Nothing beats a great investment for the price of just a few cups of coffee.
Via
The Motley Fool
Exelixis Stock Shows Rising Relative Price Performance; Still Shy Of Key Benchmark
March 27, 2023
In a welcome move, Exelixis stock saw its Relative Strength Rating improve to 73 on Monday, up from 69 a day earlier.
Via
Investor's Business Daily
3 Beaten-Down Stocks That Could Soar This Year
March 18, 2023
These stocks could enjoy big rebounds in 2023.
Via
The Motley Fool
Exelixis Stock Generating Improved Relative Strength Rating
March 16, 2023
Exelixis stock saw a welcome improvement to its Relative Strength (RS) Rating on Thursday, with an upgrade from 69 to 76.
Via
Investor's Business Daily
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector
March 15, 2023
To play a permanently relevant industry with the broadest canvas possible, consider acquiring the best biotech ETFs to buy.
Via
InvestorPlace
Nasdaq Bear Market: 5 Stunning Growth Stocks You'll Regret Not Buying on the Dip
March 11, 2023
A 33% plunge in the previously high-flying Nasdaq Composite is the perfect time for growth investors to pounce on some amazing deals.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For March 9, 2023
March 09, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.